The US female infertility diagnosis and treatment market is expected to witness a significant growth with the CAGR of 3.8% during the forecast period. The US Female infertility diagnosis and treatment diagnosis and treatment market is growing significantly due to various factors such as increasing infertility rate among females, unhealthy lifestyle and development of new technologies in IVF treatment. Apart from these factors, the rising trend of surrogacy in the country is also driving the growth of the market. According to the American Pregnancy Association in 2017, infertility affects around 6 million American couples, which corresponds to around 10% of American females of childbearing age. In addition, around 25% of infertile couples have more than one cause of infertility. The growing infertility rate creates the demand for infertility diagnosis and treatment, which in turn, drives the market growth.

A full report of US Female Infertility Diagnosis and Treatment Market is available at: https://www.omrglobal.com/industry-reports/us-female-infertility-market

The US Female infertility diagnosis and treatment market is segmented on the basis of diagnosis, treatment type, and end-user. Based on the diagnosis, the market is segmented into ovulation testing,
hysterosalpingography (HSG), hysteroscopy, imaging testing, ovarian reserve testing, hormonal level testing, genetic testing, and others (laparoscopy). Based on the treatment type, the market is segmented into drugs, surgery, intrauterine insemination (IUI), and assisted reproductive technology (ART). Based on the end-user, the market is segmented into hospitals and clinics, homecare, and pathology and diagnostic center.

To know more information, please request a free report sample https://www.omrglobal.com/request-sample/us-female-infertility-market

Some of the major players operating in the US female infertility diagnosis and treatment market include Abbott Laboratories, Inc., Merck KGaA, Cipla Ltd., and others. These players adopt various organic and inorganic growth strategies such as merger and acquisition and product launch to strengthen their presence in The US market.

US Female Infertility Diagnosis and Treatment Market – Segmentation

by Diagnosis

• Ovulation Testing
• Hysterosalpingography (HSG)
• Hysteroscopy
• Imaging Testing
• Ovarian Reserve Testing
• Hormonal Level Testing
• Genetic Testing
• Others (Laparoscopy)

by Treatment

• Drugs
• Surgery
• Intrauterine Insemination (IUI)
• Assisted Reproductive Technology (ART)

by End-User

• Hospitals and Clinics
• Homecare
• Pathology and Diagnostic Centers

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/us-female-infertility-market

Company Profiles

• Church & Dwight Co.,
• Cook Group Inc
• Eli Lilly Co.
• Fairhaven Health, LLC
• FUJIFILM Irvine Scientific, Inc.,
• Millendo Therapeutics, Inc.
• Pfizer Inc.
• Princeton BioMeditech Corp
• Bayer AG
• Church & Dwight Co., Inc.
• Vitrolife
• Cook Medical, Inc.
• Eli Lilly & Co.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 7803040404